Table: begin end state 1 21 signal peptide 22 251 non-cytoplasmic 252 276 transmembrane 277 287 cytoplasmic 288 312 transmembrane 313 323 non-cytoplasmic 324 348 transmembrane 349 367 cytoplasmic 368 388 transmembrane 389 404 non-cytoplasmic 405 424 transmembrane 425 434 cytoplasmic 435 462 transmembrane 463 481 non-cytoplasmic 482 501 transmembrane 502 507 cytoplasmic 508 528 transmembrane 529 547 non-cytoplasmic 548 570 transmembrane 571 580 cytoplasmic
Input: >AZOBR_RS32335 MANMLAVIAAGDLSTQAVLAAEALRKAAAALGHTIQVEVRSSLGVRNTLPTGAAQGAQGV ILVGSGDLGEERFAGLKRSAAALDAVLRDARAVLEQALATAPAQAPAQTGTKKIVAITSC PTGIAHTFMAAEGIQQAAQALGHAVRVETQGSVGARDTLTEQEIREADVVLIAADTQVDL ARFAGKRVFKSGTKPAINDGRALVERALAEAQPHGTAPALADGVAAGKAAKAEHAAAQRS GPYKHLMTGVSFMLPFVVTGGLLIAIAFALGGIYVFEDSQQGTLGNALFQIGAKGAFALM VPALAGYIAFSIADRPGITPGMVGGILAANLGAGFLGGIVAGFIAGYATSFLNRNIRLHK NLEGLKPVLILPLLGSLVTGLAMIYVVGAPVAEALATLSAWLKGMQGSSAILLGLLIGAM MAFDMGGPVNKAAYAFSTGLIASQVYTPMAAAMAAGMVPPLGLALATKLFADRFTREERE AGNAAGILGIAFITEGAIPFAARDPLRVIPALVLGAALTGAISMGIGAELKVPHGGIFVL PIPNAVTHLAGYVVALVAGTVTTAVALRFLKRPVSSVVTA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server